Loading
IARC estimates 7,240 new cancer cases and 5,015 cancer deaths in Mongolia in 2024; the commonest new cancers are liver and intrahepatic bile ducts, stomach and trachea, bronchus and lung. This page is assembled automatically from OnCo's data: 1 company, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 2,230 | 75.3 | Hepatocellular carcinoma |
| Stomach | 1,004 | 33.1 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 710 | 24.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 391 | 21.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Oesophagus | 353 | 12.7 | Oesophageal cancer |
| Colorectum | 349 | 11.4 | Colorectal cancer |
| Cervix uteri | 234 | 13.1 | Cervical cancer |
| Pancreas | 221 | 7.4 | Pancreatic ductal adenocarcinoma |
| Leukaemia | 148 | 4.5 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Thyroid | 145 | 4.9 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 1,867 | 63.9 | Hepatocellular carcinoma |
| Stomach | 811 | 27.6 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 578 | 20.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Oesophagus | 312 | 11.4 | Oesophageal cancer |
| Pancreas | 212 | 7.2 | Pancreatic ductal adenocarcinoma |
| Colorectum | 184 | 6.2 | Colorectal cancer |
| Cervix uteri | 142 | 8.0 | Cervical cancer |
| Brain, central nervous system | 112 | 3.6 | Glioma & glioblastoma |
| Breast | 100 | 5.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Leukaemia | 92 | 2.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in Mongolia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Mongolia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Mongolia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.